Richmond, VA (WRIC) – The Federal Drug Administration wants the makers of generic drugs to unilaterally update warning labels on their drugs, something they are not currently required to do. Do you feel generic drug labels should be updated with health safety information regularly?
The rule was first proposed in 2013, and has become increasingly controversial since then. Generic drug makers would follow the same standard of unilaterally updating drug safety information on labels; currently, only brand-name drug makers can do this without FDA permission.
The FDA proposed this rule after a 2011 U.S. Supreme Court ruling which doesn’t allow generic drug makers to update their safely labels without FDA approval. Therefore, they should not be held accountable for a failure to warn against a risk, according to the ruling.
Concerns surrounding the ruling center on generic labels being insufficient to warn patients about risks associated with certain medications. A hearing on the topic will take place next month.
Do you use generic prescription drugs? Have you ever had a bad reaction to one? Do you feel that generic drug makers should have to update warning labels for the safety of the public? 8News Investigative Reporter Kerri O’Brien wants to hear from you: call her at 804-330-8830 or email email@example.com.